During the past decade, Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" are "Metastatic Colorectal Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" in a lesser frequency.

Most popular intervention types in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cetuximab" (2 trials), "Encorafenib" (2 trials), "5-FU" (1 trials), "Bevacizumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Muenchen Klinik Neuperlach, Klinik fuer Haematologie und Onkologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".